Amgen Inc. reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported revenue was USD 6,839 million compared to USD 6,846 million a year ago. Net income was USD 1,616 million compared to USD 1,899 million a year ago. Basic earnings per share from continuing operations was USD 3.02 compared to USD 3.38 a year ago. Diluted earnings per share from continuing operations was USD 3 compared to USD 3.36 a year ago.
For the full year, revenue was USD 26,323 million compared to USD 25,979 million a year ago. Net income was USD 6,552 million compared to USD 5,893 million a year ago. Basic earnings per share from continuing operations was USD 12.18 compared to USD 10.34 a year ago. Diluted earnings per share from continuing operations was USD 12.11 compared to USD 10.28 a year ago.